Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;4(7):746-755.
doi: 10.1038/s41562-020-0908-8. Epub 2020 Jun 22.

The end of social confinement and COVID-19 re-emergence risk

Affiliations

The end of social confinement and COVID-19 re-emergence risk

Leonardo López et al. Nat Hum Behav. 2020 Jul.

Abstract

The lack of effective pharmaceutical interventions for SARS-CoV-2 raises the possibility of COVID-19 recurrence. We explore different post-confinement scenarios by using a stochastic modified SEIR (susceptible-exposed-infectious-recovered) model that accounts for the spread of infection during the latent period and also incorporates time-decaying effects due to potential loss of acquired immunity, people's increasing awareness of social distancing and the use of non-pharmaceutical interventions. Our results suggest that lockdowns should remain in place for at least 60 days to prevent epidemic growth, as well as a potentially larger second wave of SARS-CoV-2 cases occurring within months. The best-case scenario should also gradually incorporate workers in a daily proportion at most 50% higher than during the confinement period. We show that decaying immunity and particularly awareness and behaviour have 99% significant effects on both the current wave of infection and on preventing COVID-19 re-emergence. Social distancing and individual non-pharmaceutical interventions could potentially remove the need for lockdowns.

PubMed Disclaimer

References

    1. COVID-19 Coronavirus Pandemic. Worldometer https://www.worldometers.info/coronavirus/ (2020).
    1. Coronavirus Disease 2019 (COVID-19) Situation Report 126 https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... (WHO, 2020).
    1. Principi, N. & Esposito, S. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19. Lancet Infect. Dis. https://doi.org/10.1016/s1473-3099(20)30296-6 (2020).
    1. Wang, Y. et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395, 1569–1578 (2020). - DOI
    1. Chinazzi, M. et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science 368, 395–400 (2020). - PubMed - PMC

Publication types

LinkOut - more resources